Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP

E. Rabe; F. X. Breu; I. Flessenkämper; H. Gerlach; S. Guggenbichler; B. Kahle; R. Murena; S. Reich-Schupke; T. Schwarz; M. Stücker; E. Valesky; S. Werth; F. Pannier

doi:10.1007/s00105-020-04705-0

Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP

E. Rabe^*, F. X. Breu, I. Flessenkämper, H. Gerlach, S. Guggenbichler, B. Kahle, R. Murena, S. Reich-Schupke, T. Schwarz, M. Stücker, E. Valesky, S. Werth, F. Pannier

^*Corresponding author for this work

Department of Dermatology, Allergology and Venereology

20 Citations (Scopus)

Abstract

These guidelines are also consistent with the results of the first European guidelines for sclerotherapy dating from 2012 [1]. These guidelines consider the current state of the literature, but not in every case the different conditions of approval of the various drugs.

Translated title of the contribution	Leitlinie Sklerosierungsbehandlung der Varikose: S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP. Englische Version
Original language	English
Journal	Hautarzt
ISSN	0017-8470
DOIs	https://doi.org/10.1007/s00105-020-04705-0
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00105-020-04705-0

Cite this

Rabe, E., Breu, F. X., Flessenkämper, I., Gerlach, H., Guggenbichler, S., Kahle, B., Murena, R., Reich-Schupke, S., Schwarz, T., Stücker, M., Valesky, E., Werth, S., & Pannier, F. (2020). Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP. Hautarzt. https://doi.org/10.1007/s00105-020-04705-0

@article{ad4d9e04b70748daa70a824dc47e0c8f,

title = "Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft f{\"u}r Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP",

abstract = "These guidelines are also consistent with the results of the first European guidelines for sclerotherapy dating from 2012 [1]. These guidelines consider the current state of the literature, but not in every case the different conditions of approval of the various drugs. ",

author = "E. Rabe and Breu, \{F. X.\} and I. Flessenk{\"a}mper and H. Gerlach and S. Guggenbichler and B. Kahle and R. Murena and S. Reich-Schupke and T. Schwarz and M. St{\"u}cker and E. Valesky and S. Werth and F. Pannier",

year = "2020",

doi = "10.1007/s00105-020-04705-0",

language = "English",

journal = "Hautarzt",

issn = "0017-8470",

publisher = "Springer Medizin",

}

Rabe, E, Breu, FX, Flessenkämper, I, Gerlach, H, Guggenbichler, S, Kahle, B, Murena, R, Reich-Schupke, S, Schwarz, T, Stücker, M, Valesky, E, Werth, S & Pannier, F 2020, 'Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP', Hautarzt. https://doi.org/10.1007/s00105-020-04705-0

TY - JOUR

T1 - Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP

AU - Rabe, E.

AU - Breu, F. X.

AU - Flessenkämper, I.

AU - Gerlach, H.

AU - Guggenbichler, S.

AU - Kahle, B.

AU - Murena, R.

AU - Reich-Schupke, S.

AU - Schwarz, T.

AU - Stücker, M.

AU - Valesky, E.

AU - Werth, S.

AU - Pannier, F.

PY - 2020

Y1 - 2020

N2 - These guidelines are also consistent with the results of the first European guidelines for sclerotherapy dating from 2012 [1]. These guidelines consider the current state of the literature, but not in every case the different conditions of approval of the various drugs.

AB - These guidelines are also consistent with the results of the first European guidelines for sclerotherapy dating from 2012 [1]. These guidelines consider the current state of the literature, but not in every case the different conditions of approval of the various drugs.

UR - https://www.scopus.com/pages/publications/85097022572

U2 - 10.1007/s00105-020-04705-0

DO - 10.1007/s00105-020-04705-0

M3 - Scientific review articles

C2 - 33252705

AN - SCOPUS:85097022572

SN - 0017-8470

JO - Hautarzt

JF - Hautarzt

ER -

Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this